Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |